Nutex Health (NASDAQ:NUTX) Stock Rating Upgraded by Wall Street Zen

Nutex Health (NASDAQ:NUTX – Get Free Report) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Saturday, Wall Street Zen reports.

Several other research firms have also commented on NUTX. Ladenburg Thalmann & Co. Inc. assumed coverage on shares of Nutex Health in a research note on Monday, October 26th. They issued a “buy” rating and a $336.00 price objective for the company. B. Riley Financial boosted their target price on Nutex Health from $325.00 to $357.00 and gave the stock a “buy” rating in a research note on Monday, November 9th. Lake Street Capital upped their target price on Nutex Health from $310.00 to $333.00 and gave the company a “buy” rating in a report on Monday, November 9th. Zacks Research lowered Nutex Health from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 6th. Finally, Weiss Ratings downgraded Nutex Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Thursday. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $342.00.

View Our Latest Stock Analysis on NUTX

Nutex Health Stock Performance

Shares of NUTX stock opened at $173.67 on Friday. The company has a debt-to-equity ratio of 0.59, a current ratio of 4.76 and a quick ratio of 4.72. The firm has a 50-day moving average of $202.30 and a 200-day moving average of $152.07. Nutex Health has a one year low of $83.99 and a one year high of $226.16. The company has a market cap of $1.19 billion, a P/E ratio of 7.42 and a beta of 0.66.

Nutex Health (NASDAQ:NUTX – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported $5.71 earnings per share for the quarter, topping the consensus estimate of $5.54 by $0.17. Nutex Health had a net margin of 20.68% and a return on equity of 34.43%. The business had revenue of $217.61 million for the quarter, compared to analysts’ expectations of $214.82 million. Equities research analysts forecast that Nutex Health will post 27.70 EPS for the current fiscal year.

Insider Buying and Selling at Nutex Health

In related news, Director Scott Saunders sold 203 shares of the stock in a transaction dated Friday, September 18th. The shares were sold at an average price of $214.25, for a total transaction of $43,492.75. Following the completion of the transaction, the director owned 400 shares in the company, valued at approximately $85,700. This represents a 33.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 44.68% of the company’s stock.

Institutional Trading of Nutex Health

Several hedge funds have recently added to or reduced their stakes in NUTX. FORA Capital LLC bought a new position in shares of Nutex Health during the 3rd quarter valued at approximately $793,000. Empowered Funds LLC increased its stake in shares of Nutex Health by 25.7% during the 3rd quarter. Empowered Funds LLC now owns 56,806 shares of the company’s stock worth $12,024,000 after purchasing an additional 11,629 shares during the last quarter. Private Advisor Group LLC purchased a new stake in shares of Nutex Health during the 3rd quarter worth approximately $1,184,000. Voya Investment Management LLC bought a new stake in shares of Nutex Health in the 3rd quarter worth approximately $206,000. Finally, HighTower Advisors LLC bought a new stake in shares of Nutex Health in the 3rd quarter worth approximately $1,104,000. Institutional investors own 5.32% of the company’s stock.

About Nutex Health

(Get Free Report)

Nutex Health is a Houston-based healthcare company with two main divisions: a Hospital Division and a Management Services Organization (MSO). Its Hospital Division develops and operates micro-hospitals that provide emergency care and other hospital and outpatient services. Through its MSO, Nutex provides administrative, technology, analytics and other management support to affiliated physician-led organizations. These services support care coordination and population health management. Founded by physician Thomas Vo, who serves as the company’s chairman and chief executive officer, Nutex operates in the United States.

Further Reading

Analyst Recommendations for Nutex Health (NASDAQ:NUTX)

Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.